Chenxin Liu

Recombinant humanized collagen type Ⅲ-modified rapamycin liposomes for promoting osteoarthritis repair

Osteoarthritis (OA), a prevalent chronic degenerative joint disorder, affects hundreds of millions of people worldwide and has become a leading cause of joint pain and functional impairment in middle-aged and elderly populations. It not only severely compromises patients’ quality...